Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / Luke Miels
Person

Luke Miels

Tracked across 2 events · 62 articles · First seen Apr 12, 2026 · Last active Jun 10, 2026

Sentiment
35
Attention
6
Events
2
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
6 70
Business
GSK acquires Nuvalent for $10.6B
GSK plc>>> has agreed to acquire GSK plc>>>, a US cancer drug firm, for $10.6 billion (£8 billion) in an all-cash deal. This acquisition, GSK plc>>>'s largest in over a decade, aims to significantly expand…
Impact: As CEO of GSK plc>>>, Luke Miels>>> is driving the company's strategy to expand its oncology pipeline and achieve revenue targets, with the acquisition of GSK plc>>> being his first major deal.
Jun 09, 2026 · 56 articles
4 0
Tech
GSK Mo-rez Cancer Drug Shows Promise
Impact: Luke Miels, GSK plc's CEO, has emphasized speeding up new medicine development, a strategy reflected in the progress of Mo-rez.
Apr 12, 2026 · 6 articles
Relationships (2)
GSK plc ↔ Luke Miels
GSK plc ↔ Luke Miels
NEWSDESK
Track Luke Miels live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.